Treatment with Orenitram (oral treprostinil) is associated with lower healthcare-related costs than treatment with Uptravi (selexipag) in people with pulmonary arterial hypertension (PAH), a new study suggests. The study, “Medication Adherence ... Read more

As I write this, I am watching the news. Shocker, right? As of the writing of this column, 63 cases of COVID-19 have been reported in the greater Houston ... Read more